Ximelagatran is an anticoagulant medication used to prevent and treat blood clots. It is an orally administered direct thrombin inhibitor, meaning it works by directly blocking thrombin, an enzyme that helps form and maintain blood clots. Ximelagatran is used to reduce the risk of stroke and other serious blood clot-related conditions, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent blood clots in people who have had hip or knee replacement surgery.
Ximelagatran was a medication intended to be a replacement for warfarin, a blood thinner that requires frequent monitoring and can interact with certain foods and medications. Ximelagatran belonged to a class of medications called direct thrombin inhibitors, which work by blocking the action of thrombin, a substance in the blood that helps clots form.
Ximelagatran was taken orally as a tablet, but it never reached the market due to safety concerns. Development of the drug was discontinued in 2006 after reports of liver damage in patients taking the medication.
Here are some other details about Ximelagatran:
- Mechanism of action: Ximelagatran is a prodrug, meaning it is converted into its active form, melagatran, after it is taken into the body.
- Benefits: Ximelagatran has several potential benefits over warfarin, including:
- No need for routine monitoring of blood clotting times
- Less potential for food and drug interactions
- Fixed dosing
- Side effects: The most serious side effect of Ximelagatran is liver damage.